![]() |
市場調查報告書
商品編碼
2048271
獸醫即時診斷市場-全球產業規模、佔有率、趨勢、機會、預測:按產品、動物種類、樣本類型、適應症、檢測類別、最終用戶、地區和競爭格局分類,2021-2031年Veterinary Point of Care Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Animal Type, By Sample Type, By Indication, By Testing Category, By End User By Region & Competition, 2021-2031F |
||||||
全球獸醫照護現場診斷市場預計將大幅成長,從 2025 年的 21.2 億美元成長到 2031 年的 39.2 億美元,複合年成長率達到 10.79%。
這些診斷設備包括攜帶式設備和耗材,使獸醫能夠在動物診療環境中進行即時分析,從而減少轉診至外部實驗室的需求。這個市場的主要驅動力是伴侶動物飼養率的不斷提高以及飼主越來越願意為寵物投資高品質的醫療服務。這種需求的成長要求獸醫具備快速臨床決策能力,以便在一次診療中即可做出診斷並開始治療。歐洲獸醫診斷與治療聯合會(FEDIAF)的報告顯示,到2025年,歐洲將有1.39億戶家庭至少擁有一隻寵物,足以說明市場規模之大。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 21.2億美元 |
| 市場規模:2031年 | 39.2億美元 |
| 複合年成長率:2026-2031年 | 10.79% |
| 成長最快的細分市場 | 居家照護 |
| 最大的市場 | 北美洲 |
儘管成長預期強勁,但由於熟練獸醫專業人員短缺,市場面臨重大挑戰。這種人才短缺限制了診所高效實施和管理新的診斷流程的能力,導致現有技術未能充分利用,並阻礙了即時檢測在獸醫實踐中的整體推廣。
攜帶式和自動化診斷系統的技術進步正在從根本上改變全球獸醫照護現場診斷市場,使獸醫能夠在診所內直接獲得與外部實驗室品質相當的檢測結果。將人工智慧 (AI) 和連接功能整合到桌上型分析儀中,使獸醫能夠即時、準確地分析複雜的檢體,從而實現即時治療決策。這種轉變正迅速加速全球先進硬體的普及。例如,IDEXX Laboratories, Inc. 報告稱,僅在 2025 年的一個季度,其創新 inVue Dx 設備就已在全球安裝了超過 1700 台,這反映出市場對這些先進功能的強勁需求。此外,不斷上漲的動物醫療保健成本和日益成長的寵物保險正在消除全面檢測的經濟障礙,從而刺激市場擴張。隨著保險覆蓋範圍的擴大,寵物飼主可以在初次就診時無需擔心過高的費用,即可要求進行全面的診斷檢測,從而提高了即時診斷設備的使用率。這項財政支持非常巨大,北美寵物健康保險協會 (NAPHIA) 報告稱,到 2024 年底,保費總收入將超過 52 億美元;美國寵物產品協會 (APPA) 預測,到 2025 年,美國寵物行業的總支出將達到 1520 億美元。
獸醫專業人員短缺是限制全球獸醫照護現場診斷市場成長的一大瓶頸。雖然照護現場設備旨在加快臨床決策,但它們需要一定數量的人員進行操作、解讀和維護。在面臨人力短缺的診所,現有獸醫團隊往往不堪重負,缺乏資源來實施新的診斷流程或為先進的可攜式系統提供必要的培訓。因此,診所經常將檢體送到外部實驗室以節省人力,這實際上抵消了推動即時診斷解決方案普及的「速度」優勢。這種人員限制導致診所所有者不願投資昂貴的技術,嚴重影響了市場擴張。英國獸醫協會 (BVA) 在 2024 年報告中指出,超過三分之一的獸醫對自己在行業中的未來感到不確定,或者正在積極計劃離開這個行業。這加劇了勞動力短缺危機,並凸顯了高離職率的可能性,這直接限制了診所使用和證明即時診斷設備成本合理性的能力。
微流體和晶片實驗室技術的進步,將複雜的流體處理流程微型化,整合到一次性試劑盒中,從根本上改變了獸醫醫院的運作效率和面積。這項技術變革使獸醫能夠分析檢體,這對於兒童動物和脫水動物患者至關重要。同時,它也省去了傳統桌上型系統通常需要的大規模維護和液體試劑儲存。這些緊湊型設備能夠精確控制亞毫米級的流體,無需大規模實驗室基礎設施即可進行即時分析和細胞排列。例如,碩騰公司(Zoetis)於2024年9月發布的「Vetscan OptiCell」診斷設備,採用專有的微流體技術將血球排列成單層進行分析,這標誌著與傳統流式細胞技術的重大變革。
同時,市場正經歷著向雲端臨床管理系統整合化的決定性轉變,診斷設備正從獨立工具轉變為綜合數位生態系統中的互聯節點。這一趨勢的重點在於透過將臨床硬體與患者資訊系統直接同步來簡化工作流程,並透過將檢測結果自動整合到醫療記錄中來確保計費的準確性,從而避免人為錯誤。獸醫院正優先採用這些整合平台,以促進患者的長期後續觀察並減輕與大量檢測相關的管理負擔。例如,IDEXX Laboratories, Inc. 報告稱,其獸醫軟體、服務和診斷影像部門在 2024 年第三季的收入成長了 11%,這主要得益於其雲端軟體解決方案持續兩位數的內部成長。
The Global Veterinary Point of Care Diagnostics Market is projected to see significant growth, expanding from USD 2.12 Billion in 2025 to USD 3.92 Billion by 2031, achieving a Compound Annual Growth Rate (CAGR) of 10.79%. These diagnostics consist of portable instruments and consumables that enable veterinarians to perform immediate analyses at the animal care site, thereby reducing the need for external reference laboratories. This market is primarily driven by the increasing prevalence of companion animal ownership and owners' growing willingness to invest in premium healthcare services for their pets. This escalating demand necessitates rapid clinical decision-making capabilities, allowing practitioners to diagnose and initiate treatment within a single consultation. As an indicator of this substantial market base, FEDIAF reported that 139 million European households owned at least one pet in 2025.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 2.12 Billion |
| Market Size 2031 | USD 3.92 Billion |
| CAGR 2026-2031 | 10.79% |
| Fastest Growing Segment | Home Care Settings |
| Largest Market | North America |
Despite these strong growth projections, the market faces a significant hurdle due to the shortage of skilled veterinary professionals. This scarcity limits clinics' capacity to efficiently adopt and manage new diagnostic workflows, leading to underutilization of available technologies and impeding the overall expansion of point-of-care testing within veterinary practices.
Market Driver
Technological advancements in portable and automated diagnostic systems are fundamentally transforming the Global Veterinary Point of Care Diagnostics Market by providing reference-lab quality results directly within the clinic. The integration of artificial intelligence and connectivity into benchtop analyzers empowers veterinarians with immediate, accurate interpretations of complex samples, enabling real-time treatment decisions. This shift is rapidly accelerating the installation of sophisticated hardware worldwide; for instance, IDEXX Laboratories, Inc. reported placing over 1,700 units of its innovative inVue Dx instruments globally in just one quarter during 2025, reflecting intense demand for these advanced capabilities. Furthermore, increasing animal healthcare expenditure and the growing penetration of pet insurance are catalyzing market expansion by removing financial obstacles to comprehensive testing. As insurance coverage becomes more widespread, pet owners are increasingly able to authorize extensive diagnostic panels during initial visits without undue cost concerns, leading to higher utilization rates of point-of-care devices. This financial support is substantial, with the North American Pet Health Insurance Association (NAPHIA) reporting total written premiums exceeding $5.2 billion USD by the end of 2024, complemented by total pet industry expenditures in the United States reaching $152 billion in 2025, according to the American Pet Products Association.
Market Challenge
The shortage of skilled veterinary professionals represents a critical bottleneck hindering the growth of the Global Veterinary Point of Care Diagnostics Market. While point-of-care devices are designed to accelerate clinical decision-making, they require a baseline of available personnel to operate, interpret results from, and maintain the equipment. Clinics facing staffing deficits often find their existing veterinary teams overwhelmed with patient volume, leaving insufficient capacity to integrate new diagnostic workflows or undergo necessary training for advanced portable systems. Consequently, practices frequently revert to sending samples to external reference laboratories to conserve immediate staff resources, effectively negating the speed advantage that drives the adoption of point-of-care solutions. This labor constraint severely impacts market expansion by creating an environment where practice owners are hesitant to invest in premium technology. The British Veterinary Association reported in 2024 that over one-third of veterinarians were unsure of their future in the sector or actively planning to leave, highlighting a high potential turnover that exacerbates the workforce crisis and directly limits the capacity of veterinary clinics to utilize and justify the cost of immediate diagnostic instruments.
Market Trends
Advancements in microfluidic and lab-on-a-chip technologies are fundamentally altering the operational efficiency and physical footprint of veterinary clinics by miniaturizing complex fluid handling into single-use cartridges. This technological shift enables practitioners to analyze significantly smaller sample volumes, which is crucial for pediatric or dehydrated animal patients, while also eliminating the extensive maintenance and liquid reagent storage typically associated with traditional benchtop systems. By precisely manipulating fluids at the sub-millimeter scale, these compact devices facilitate immediate analysis and cellular alignment without requiring large-scale laboratory infrastructure. An example is Zoetis Inc.'s September 2024 unveiling of the Vetscan OptiCell, a diagnostic instrument utilizing proprietary microfluidic technology to align blood cells in a single layer for analysis, marking a significant departure from standard flow cytometry methods.
Concurrently, the market is undergoing a decisive shift towards cloud-based practice management integration, which transforms diagnostic instruments from standalone tools into connected nodes within a comprehensive digital ecosystem. This trend focuses on improving workflow efficiency by directly synchronizing point-of-care hardware with patient information systems, ensuring test results are automatically populated into medical records to prevent manual entry errors and guarantee accurate billing capture. Veterinary practices are prioritizing these integrated platforms to facilitate longitudinal patient tracking and streamline the administrative burden associated with high-volume testing. For instance, IDEXX Laboratories, Inc. reported an 11% increase in revenue from its Veterinary Software, Services and Diagnostic Imaging segment in Q3 2024, a performance primarily driven by the continued double-digit organic growth of its cloud-based software solutions.
Report Scope
In this report, the Global Veterinary Point of Care Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Point of Care Diagnostics Market.
Global Veterinary Point of Care Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: